Market by Type, Form, Livestock, Application, End-user, and Geography | Forecast 2021-2028
Eubiotics are types of feed additives comprising prebiotics, probiotics, essential oils, and organic acids. The primary goal of administering eubiotics is to maintain intestine eubiosis, resulting in enhanced health and performance in farm animals. Besides, it has proven to be a viable alternative to antibiotics. As per Triton Market Research, the global market for eubiotics was valued at $4239.22 million in 2020 and is expected to reach $7521.10 million by 2028, growing at a CAGR of 7.43% during the forecast period.
Triton’s report on eubiotics provides
an in-depth insight into the market. The detailed analysis of the market
includes key insights, Porter’s five forces analysis, market attractiveness
index, vendor scorecard, key strategies, and impact of COVID-19 on the eubiotics
market.
The studied market is driven
by several factors such as rising meat consumption, growing awareness and
concerns regarding animal health, and increasing demand for manufactured feeds.
Here, the rising meat consumption due to the growing global population,
industrialization, and shifting consumer habits have increased the demand for
eubiotics. Besides, meat production has surged fourfold over the years globally.
As per estimates, poultry (mainly chicken), pig meat, and beef make up over 92%
of global meat production. Moreover, over 300 million cattle and 1.5 billion
pigs are slaughtered for human meat consumption annually. Further, the
increased meat consumption has raised concerns regarding meat quality,
encouraging consumers to utilize eubiotics to produce healthy meat.
Furthermore, in recent years,
eubiotics have emerged as a potential solution to the issue of antimicrobial
resistance (AMR) since the spread of antibiotic resistance has become a global
hazard. In addition, eubiotics include a multitude of beneficial chemicals that
improve gut health and reinforce the protective layers of the GI tract. As a
result, eubiotics are widely used in calves, aiding their growth and
development. Moreover, eubiotics treat necrotic enteritis, one of the biggest
gut health issues chicken farmers face, leading to enormous economic losses.
Conversely, the market has been impacted due to unawareness relating to eubiotics. Animal production in several nations is threatened by antibiotics, contributing to the growth of antimicrobial resistance (AMR). Moreover, farmers continue to use antibiotics despite bans in many countries. Besides, several farmers are unaware of the harmful consequences of antibiotics and the efficacy of eubiotics. Hence, the lack of awareness about the benefits of eubiotics puts the global market at risk.
Major
geographies covered in the global eubiotics market are:
• North America: United States and Canada
• Europe: United Kingdom, France, Germany, Spain, Italy,
Russia, and Rest of Europe
• Asia-Pacific: China, Japan, India, Australia & New
Zealand, South Korea, ASEAN Countries, and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East and Africa: Saudi Arabia, Turkey, United Arab
Emirates, South Africa, and Rest of Middle East & Africa
The
segmentation analysis of the eubiotics market includes:
• Type segment includes:
o Probiotics
o Organic
Acid
o Prebiotics
o Essential
Oils
• Form segment includes:
o Dry
o Liquid
• Livestock segment includes:
o Swine
o Poultry
o Ruminants
o Aquaculture
o Other
Livestock
• Application segment includes:
o Gut
Health
o Immunity
o Yield
Management
o Other
Applications
• End-user segment includes:
o Animals
o Humans
The distinguished companies
thriving in the eubiotics market comprises BASF SE, Cargill Inc, Dupont De
Nemours Inc, Koninklijke DSM NV, Archer Daniels Midland, Beneo GmbH, Neospark
Drugs and Chemicals Private Limited, Kemin Industries Inc, Behn Meyer Group,
Lesaffre, Novus International Inc, Yara International ASA, Anpario Plc,
Lallemand Inc, and CHR Hansen Holding AS.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
EUBIOTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON EUBIOTICS MARKET
2.2. KEY
INSIGHTS
2.2.1. EUBIOTICS
AS AN ALTERNATIVE TO ANTIBIOTICS
2.2.2. APPLICATIONS
OF EUBIOTICS IN CALVES’ GUT HEALTH
2.2.3. DEVELOPING
FOOD ADDITIVE PLATFORM BASED ON GRAINS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. PRODUCT
LAUNCHES
2.6.4. EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISING
MEAT CONSUMPTION
2.7.2. GROWING
AWARENESS AND CONCERNS REGARDING ANIMAL HEALTH
2.7.3. INCREASING
DEMAND FOR MANUFACTURED FEEDS
2.8. MARKET
CHALLENGES
2.8.1. UNAWARENESS
ABOUT EUBIOTICS
2.9. MARKET
OPPORTUNITIES
2.9.1. GOVERNMENT
SUPPORT FOR EUBIOTICS USE
2.9.2. PROBIOTICS
SPRAY COATINGS
2.9.3. ESSENTIAL
OILS FOR NECROTIC ENTERITIS
3. GLOBAL
EUBIOTICS MARKET OUTLOOK - BY TYPE
3.1. PROBIOTICS
3.2. ORGANIC
ACID
3.3. PREBIOTICS
3.4. ESSENTIAL
OILS
4. GLOBAL
EUBIOTICS MARKET OUTLOOK - BY FORM
4.1. DRY
4.2. LIQUID
5. GLOBAL
EUBIOTICS MARKET OUTLOOK - BY LIVESTOCK
5.1. SWINE
5.2. POULTRY
5.3. RUMINANTS
5.4. AQUACULTURE
5.5. OTHER
LIVESTOCK
6. GLOBAL
EUBIOTICS MARKET OUTLOOK - BY APPLICATION
6.1. GUT
HEALTH
6.2. IMMUNITY
6.3. YIELD
MANAGEMENT
6.4. OTHER
APPLICATIONS
7. GLOBAL
EUBIOTICS MARKET OUTLOOK - BY END-USER
7.1. ANIMALS
7.2. HUMANS
8. GLOBAL
EUBIOTICS MARKET – REGIONAL OUTLOOK
8.1. NORTH
AMERICA
8.1.1. MARKET
BY TYPE
8.1.2. MARKET
BY FORM
8.1.3. MARKET
BY LIVESTOCK
8.1.4. MARKET
BY APPLICATION
8.1.5. MARKET
BY END-USER
8.1.6. COUNTRY
ANALYSIS
8.1.6.1. UNITED
STATES
8.1.6.2. CANADA
8.2. EUROPE
8.2.1. MARKET
BY TYPE
8.2.2. MARKET
BY FORM
8.2.3. MARKET
BY LIVESTOCK
8.2.4. MARKET
BY APPLICATION
8.2.5. MARKET
BY END-USER
8.2.6. COUNTRY
ANALYSIS
8.2.6.1. UNITED
KINGDOM
8.2.6.2. GERMANY
8.2.6.3. FRANCE
8.2.6.4. SPAIN
8.2.6.5. ITALY
8.2.6.6. RUSSIA
8.2.6.7. REST
OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET
BY TYPE
8.3.2. MARKET
BY FORM
8.3.3. MARKET
BY LIVESTOCK
8.3.4. MARKET
BY APPLICATION
8.3.5. MARKET
BY END-USER
8.3.6. COUNTRY
ANALYSIS
8.3.6.1. CHINA
8.3.6.2. JAPAN
8.3.6.3. INDIA
8.3.6.4. SOUTH
KOREA
8.3.6.5. ASEAN
COUNTRIES
8.3.6.6. AUSTRALIA
& NEW ZEALAND
8.3.6.7. REST
OF ASIA-PACIFIC
8.4. LATIN
AMERICA
8.4.1. MARKET
BY TYPE
8.4.2. MARKET
BY FORM
8.4.3. MARKET
BY LIVESTOCK
8.4.4. MARKET
BY APPLICATION
8.4.5. MARKET
BY END-USER
8.4.6. COUNTRY
ANALYSIS
8.4.6.1. BRAZIL
8.4.6.2. MEXICO
8.4.6.3. REST
OF LATIN AMERICA
8.5. MIDDLE
EAST AND AFRICA
8.5.1. MARKET
BY TYPE
8.5.2. MARKET
BY FORM
8.5.3. MARKET
BY LIVESTOCK
8.5.4. MARKET
BY APPLICATION
8.5.5. MARKET
BY END-USER
8.5.6. COUNTRY
ANALYSIS
8.5.6.1. UNITED
ARAB EMIRATES
8.5.6.2. SAUDI
ARABIA
8.5.6.3. TURKEY
8.5.6.4. SOUTH
AFRICA
8.5.6.5. REST
OF MIDDLE EAST & AFRICA
9. COMPETITIVE
LANDSCAPE
9.1. ANPARIO
PLC
9.2. ARCHER
DANIELS MIDLAND
9.3. BASF
SE
9.4. BEHN
MEYER GROUP
9.5. BENEO
GMBH
9.6. CARGILL
INC
9.7. CHR
HANSEN HOLDING AS
9.8. DUPONT
DE NEMOURS INC
9.9. KEMIN
INDUSTRIES INC
9.10. KONINKLIJKE
DSM NV
9.11. LALLEMAND
INC
9.12. LESAFFRE
9.13. NEOSPARK
DRUGS AND CHEMICALS PRIVATE LIMITED
9.14. NOVUS
INTERNATIONAL INC
9.15. YARA
INTERNATIONAL ASA
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL
EUBIOTICS MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: COUNTRIES WITH
THE HIGHEST ANNUAL MEAT CONSUMPTION
TABLE 4: MAJOR LIVESTOCK
DISEASES IN THE WORLD
TABLE 5: GLOBAL
EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL
EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 7: GLOBAL
EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL
EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL
EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL
EUBIOTICS MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA
EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA
EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA
EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA
EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA
EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 18: EUROPE
EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 19: EUROPE
EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 20: EUROPE
EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 21: EUROPE
EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 22: EUROPE
EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC
EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC
EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC
EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC
EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC
EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 29: LATIN AMERICA
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA
EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 31: LATIN AMERICA
EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 32: LATIN AMERICA
EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 33: LATIN AMERICA
EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 34: LATIN AMERICA
EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND
AFRICA EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND
AFRICA EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND
AFRICA EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 38: MIDDLE EAST AND
AFRICA EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 39: MIDDLE EAST AND
AFRICA EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 40: MIDDLE EAST AND
AFRICA EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: GLOBAL EUBIOTICS MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE 3: GLOBAL EUBIOTICS MARKET, BY PROBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 4: GLOBAL EUBIOTICS MARKET, BY ORGANIC ACID, 2021-2028 (IN $
MILLION)
FIGURE 5: GLOBAL EUBIOTICS MARKET, BY PREBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 6: GLOBAL EUBIOTICS MARKET, BY ESSENTIAL OILS, 2021-2028 (IN $
MILLION)
FIGURE 7: GLOBAL EUBIOTICS MARKET, BY FORM, 2020 & 2028 (IN %)
FIGURE 8: GLOBAL EUBIOTICS MARKET, BY DRY, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL EUBIOTICS MARKET, BY LIQUID, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL EUBIOTICS MARKET, BY LIVESTOCK, 2020 & 2028 (IN %)
FIGURE 11: GLOBAL EUBIOTICS MARKET, BY SWINE, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL EUBIOTICS MARKET, BY POULTRY, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL EUBIOTICS MARKET, BY RUMINANTS, 2021-2028 (IN $
MILLION)
FIGURE 14: GLOBAL EUBIOTICS MARKET, BY AQUACULTURE, 2021-2028 (IN $
MILLION)
FIGURE 15: GLOBAL EUBIOTICS MARKET, BY OTHER LIVESTOCK, 2021-2028 (IN $
MILLION)
FIGURE 16: GLOBAL EUBIOTICS MARKET, BY APPLICATION, 2020 & 2028 (IN
%)
FIGURE 17: GLOBAL EUBIOTICS MARKET, BY GUT HEALTH, 2021-2028 (IN $
MILLION)
FIGURE 18: GLOBAL EUBIOTICS MARKET, BY IMMUNITY, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL EUBIOTICS MARKET, BY YIELD MANAGEMENT, 2021-2028 (IN $
MILLION)
FIGURE 20: GLOBAL EUBIOTICS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN
$ MILLION)
FIGURE 21: GLOBAL EUBIOTICS MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE 22: GLOBAL EUBIOTICS MARKET, BY ANIMALS, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL EUBIOTICS MARKET, BY HUMANS, 2021-2028 (IN $ MILLION)
FIGURE 24: GLOBAL EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN
%)
FIGURE 25: UNITED STATES EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: CANADA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: UNITED KINGDOM EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: GERMANY EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: FRANCE EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: SPAIN EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: ITALY EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: RUSSIA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: REST OF EUROPE EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: CHINA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: JAPAN EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: INDIA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: SOUTH KOREA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: ASEAN COUNTRIES EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: AUSTRALIA & NEW ZEALAND EUBIOTICS MARKET 2021-2028 (IN $
MILLION)
FIGURE 40: REST OF ASIA-PACIFIC EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: BRAZIL EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: MEXICO EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: REST OF LATIN AMERICA EUBIOTICS MARKET 2021-2028 (IN $
MILLION)
FIGURE 44: UNITED ARAB EMIRATES EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: SAUDI ARABIA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: TURKEY EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: SOUTH AFRICA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 48: REST OF MIDDLE EAST & AFRICA EUBIOTICS MARKET 2021-2028
(IN $ MILLION)